GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » New Frontier Health Corp (NYSE:NFH) » Definitions » EV-to-EBITDA

New Frontier Health (New Frontier Health) EV-to-EBITDA : 47.34 (As of May. 12, 2024)


View and export this data going back to 2018. Start your Free Trial

What is New Frontier Health EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, New Frontier Health's enterprise value is $2,065.6 Mil. New Frontier Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2020 was $43.6 Mil. Therefore, New Frontier Health's EV-to-EBITDA for today is 47.34.

The historical rank and industry rank for New Frontier Health's EV-to-EBITDA or its related term are showing as below:

NFH's EV-to-EBITDA is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 13.065
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-12), New Frontier Health's stock price is $11.95. New Frontier Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2020 was $-0.435. Therefore, New Frontier Health's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


New Frontier Health EV-to-EBITDA Historical Data

The historical data trend for New Frontier Health's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

New Frontier Health EV-to-EBITDA Chart

New Frontier Health Annual Data
Trend Dec17 Dec18 Dec19 Dec20
EV-to-EBITDA
- 40.34 40.73 35.97

New Frontier Health Quarterly Data
Dec17 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 40.73 50.69 43.48 33.40 35.97

Competitive Comparison of New Frontier Health's EV-to-EBITDA

For the Medical Care Facilities subindustry, New Frontier Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


New Frontier Health's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, New Frontier Health's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where New Frontier Health's EV-to-EBITDA falls into.



New Frontier Health EV-to-EBITDA Calculation

New Frontier Health's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=2065.629/43.638
=47.34

New Frontier Health's current Enterprise Value is $2,065.6 Mil.
New Frontier Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $43.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


New Frontier Health  (NYSE:NFH) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

New Frontier Health's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=11.95/-0.435
=At Loss

New Frontier Health's share price for today is $11.95.
New Frontier Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.435.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


New Frontier Health EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of New Frontier Health's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


New Frontier Health (New Frontier Health) Business Description

Traded in Other Exchanges
N/A
Address
10 Jiuxianqiao Road, B7 Building, 1ST Floor, Hengtong Business Park, Chaoyang District, Beijing, CHN, 100015
New Frontier Health Corp is a comprehensive private medical service platform. Through its subsidiary, it provides healthcare services throughout the life cycle in China. The firm's operating segments are Operating assets Tier 1, and Operating assets Tier 2 and other assets and Expansion assets. Tier 1 segment consists of the group's existing general hospitals and clinics located in tier 1 cities in China, such as Beijing and Shanghai whereas, tier 2 and other assets segment consists of the group's existing general hospitals and clinics located in tier 2 cities in China, such as Tianjin and Qingdao, and specialized healthcare facilities. The company generates a majority of its revenue from the Tier 1 segment.

New Frontier Health (New Frontier Health) Headlines

From GuruFocus